A non-interventional study to evaluate the safety and effectiveness of a biphasic, chondrocyte-containing biomaterial (NOVOCART ® 3D) in the treatment of localized full-thickness cartilage defects or osteochondral lesions of the knee joint (NISANIK)
Objectives and questions: The focus of this study was to evaluate the safety of NOVOCART® 3D-treatment over a period of 36 months post-transplantation. The secondary aim was to assess the enhancement of functional abilities and performance in both adult and adolescent patients undergoing treatment [for full text, please go to the a.m. URL]
Institutions
- OTH Regensburg (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- TUM Klinikum (DE)
- University Hospital Regensburg (DE)
- Marienkrankenhaus Hamburg (DE)
- Klinikum Arnsberg (DE)
- Klinikum Sindelfingen-Böblingen (DE)
- Sozialstiftung Bamberg (DE)
- Schmerzklinik Kiel (DE)
- Heidelberg University (US)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-10-31
- DOI
- https://doi.org/10.3205/25dkou398
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00